|Class||Name/Company||Approval Dates and Comments|
Approved in Canada, May 1998 for the topical treatment of
Recently approved by the FDA for 14 indications including
Approved by the EC Commision. Combivir aims to
Recently approved by the FDA for the treatment of photoinduced
The US FDA issued an approvable letter in June 2000, for the treatment of oral facial herpes. Docosanol is the first approvable OTC treatment for this disease.
Gensia Sicor Pharmaceuticals
The US FDA tentatively approved Gensia Sicor Pharmaceuticals’ ANDA in June 2000, for the generic injection form of Bristol-Myers Squibb’s bleomycin (Blenoxane). If fully approved, bleomycin will be used alone or in combination with other chemotherapeutic agents for the management of squamous cell carcinoma, lymphomas and testicular carcinoma.
Approved in India, this vaccine is said to be the first to
A preliminary report from workers in Boston suggests that
|New Side Effect|
Lumps, humps and bumps of mature pockets of adipose tissue have been described in patients